Targeted Cancer Therapy

Targeted Cancer Therapy is one of the chief means of medical treatment for Cancer. Targeted Therapy blocks the development of Cancer cells by interfering with Specific Targeted Molecules required for carcinogenesis and tumor growth rather than by simply interfering with all rapidly dividing cells. Targeted Cancer Therapies are likely to be more effective than older forms of treatments and less harmful to normal cells. Numerous Targeted Therapies are examples of immunotherapy using immune mechanisms for therapeutic purposes developed by the field of cancer immunology. So, as immunomodulators, they are one type of biological response modifiers.

 

  • FDA approved Targeted Therapies for Cancer
  • Monoclonal Antibody-conjugated Nanoparticles for Targeted Cancer Therapy
  • Types of targeted therapies: hormone therapies, signal transduction inhibitors, expression modulators, apoptosis inducers, angiogenesis inhibitors, toxin delivery molecules etc.
  • Molecular targeted therapies

Related Conference of Targeted Cancer Therapy

June 10-11, 2024

8th Global Meeting on Oncology and Radiology

Barcelona, Spain
July 11-12, 2024

24th World Congress on Cancer and Diagnostics

Vancouver, Canada
July 18-19, 2024

14th World Congress on Breast Cancer

Paris, France
September 16-17, 2024

9th World Conference on Breast and Cervical Cancer

London, UK
September 19-20, 2024

25th World Congress on Cancer Summit

Paris, France
November 24-25, 2024

7th International Conference on Anti-Cancer Drugs

Vancouver, Canada

Targeted Cancer Therapy Conference Speakers

    Recommended Sessions

    Related Journals

    Are you interested in